1
|
Giorgioni G, Bonifazi A, Botticelli L, Cifani C, Matteucci F, Micioni Di Bonaventura E, Micioni Di Bonaventura MV, Giannella M, Piergentili A, Piergentili A, Quaglia W, Del Bello F. Advances in drug design and therapeutic potential of selective or multitarget 5-HT1A receptor ligands. Med Res Rev 2024. [PMID: 38808959 DOI: 10.1002/med.22049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2023] [Revised: 03/14/2024] [Accepted: 05/03/2024] [Indexed: 05/30/2024]
Abstract
5-HT1A receptor (5-HT1A-R) is a serotoninergic G-protein coupled receptor subtype which contributes to several physiological processes in both central nervous system and periphery. Despite being the first 5-HT-R identified, cloned and studied, it still represents a very attractive target in drug discovery and continues to be the focus of a myriad of drug discovery campaigns due to its involvement in numerous neuropsychiatric disorders. The structure-activity relationship studies (SAR) performed over the last years have been devoted to three main goals: (i) design and synthesis of 5-HT1A-R selective/preferential ligands; (ii) identification of 5-HT1A-R biased agonists, differentiating pre- versus post-synaptic agonism and signaling cellular mechanisms; (iii) development of multitarget compounds endowed with well-defined poly-pharmacological profiles targeting 5-HT1A-R along with other serotonin receptors, serotonin transporter (SERT), D2-like receptors and/or enzymes, such as acetylcholinesterase and phosphodiesterase, as a promising strategy for the management of complex psychiatric and neurodegenerative disorders. In this review, medicinal chemistry aspects of ligands acting as selective/preferential or multitarget 5-HT1A-R agonists and antagonists belonging to different chemotypes and developed in the last 7 years (2017-2023) have been discussed. The development of chemical and pharmacological 5-HT1A-R tools for molecular imaging have also been described. Finally, the pharmacological interest of 5-HT1A-R and the therapeutic potential of ligands targeting this receptor have been considered.
Collapse
Affiliation(s)
- Gianfabio Giorgioni
- Medicinal Chemistry Unit, School of Pharmacy, University of Camerino, Camerino, Italy
| | - Alessandro Bonifazi
- Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, Baltimore, Maryland, USA
| | - Luca Botticelli
- Pharmacology Unit, School of Pharmacy, University of Camerino, Camerino, Italy
| | - Carlo Cifani
- Pharmacology Unit, School of Pharmacy, University of Camerino, Camerino, Italy
| | - Federica Matteucci
- Medicinal Chemistry Unit, School of Pharmacy, University of Camerino, Camerino, Italy
| | | | | | - Mario Giannella
- Medicinal Chemistry Unit, School of Pharmacy, University of Camerino, Camerino, Italy
| | | | - Alessia Piergentili
- Medicinal Chemistry Unit, School of Pharmacy, University of Camerino, Camerino, Italy
| | - Wilma Quaglia
- Medicinal Chemistry Unit, School of Pharmacy, University of Camerino, Camerino, Italy
| | - Fabio Del Bello
- Medicinal Chemistry Unit, School of Pharmacy, University of Camerino, Camerino, Italy
| |
Collapse
|
2
|
Andreozzi G, Ambrosio MR, Magli E, Maneli G, Severino B, Corvino A, Sparaco R, Perissutti E, Frecentese F, Santagada V, Leśniak A, Bujalska-Zadrożny M, Caliendo G, Formisano P, Fiorino F. Design, Synthesis and Biological Evaluation of Novel N-Arylpiperazines Containing a 4,5-Dihydrothiazole Ring. Pharmaceuticals (Basel) 2023; 16:1483. [PMID: 37895954 PMCID: PMC10609883 DOI: 10.3390/ph16101483] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2023] [Revised: 10/03/2023] [Accepted: 10/16/2023] [Indexed: 10/29/2023] Open
Abstract
Arylpiperazines represent one of the most important classes of 5-HT1AR ligands and have attracted considerable interests for their versatile properties in chemistry and pharmacology, leading to the research of new derivatives that has been focused on the modification of one or more portions of such pharmacophore. An efficient protocol for the synthesis of novel thiazolinylphenyl-piperazines (2a-c) and the corresponding acetylated derivatives was used (3a-c). The new compounds were tested for their functional activity and affinity at 5-HT1A receptors, showing an interesting affinity profile with a Ki value of 412 nM for compound 2b. The cytotoxic activity of novel thiazolinylphenyl-piperazines (2a-c) and corresponding N-acetyl derivatives (3a-c) against human prostate and breast cancer cell lines (LNCAP, DU-145 and PC-3, MCF-7, SKBR-3 and MDA-MB231) was investigated according to the procedure described in the literature. The reported data showed a cytotoxic effect for 2a-c and 3a-c compounds (IC50 values ranging from 15 µM to 73 µM) on the investigated cancer cell lines, with no effect on noncancer cells. Future studies will be aimed to investigate the mechanism of action and therapeutic prospects of these new scaffolds.
Collapse
Affiliation(s)
- Giorgia Andreozzi
- Dipartimento di Farmacia, Università di Napoli Federico II, Via D. Montesano, 49, 80131 Naples, Italy; (G.A.); (B.S.); (A.C.); (R.S.); (E.P.); (F.F.); (V.S.); (G.C.)
| | - Maria Rosaria Ambrosio
- URT “Genomic of Diabetes”, Institute for Experimental Endocrinology and Oncology “G. Salvatore”, National Research Council (IEOS-CNR), Via Pansini 5, 80131 Naples, Italy; (M.R.A.); (P.F.)
| | - Elisa Magli
- Dipartimento di Sanità Pubblica, Università di Napoli Federico II, Via Pansini, 5, 80131, Naples, Italy;
| | - Giovanni Maneli
- Department of Translational Medicine, University of Naples “Federico II”, Via Pansini 5, 80131 Naples, Italy;
| | - Beatrice Severino
- Dipartimento di Farmacia, Università di Napoli Federico II, Via D. Montesano, 49, 80131 Naples, Italy; (G.A.); (B.S.); (A.C.); (R.S.); (E.P.); (F.F.); (V.S.); (G.C.)
| | - Angela Corvino
- Dipartimento di Farmacia, Università di Napoli Federico II, Via D. Montesano, 49, 80131 Naples, Italy; (G.A.); (B.S.); (A.C.); (R.S.); (E.P.); (F.F.); (V.S.); (G.C.)
| | - Rosa Sparaco
- Dipartimento di Farmacia, Università di Napoli Federico II, Via D. Montesano, 49, 80131 Naples, Italy; (G.A.); (B.S.); (A.C.); (R.S.); (E.P.); (F.F.); (V.S.); (G.C.)
| | - Elisa Perissutti
- Dipartimento di Farmacia, Università di Napoli Federico II, Via D. Montesano, 49, 80131 Naples, Italy; (G.A.); (B.S.); (A.C.); (R.S.); (E.P.); (F.F.); (V.S.); (G.C.)
| | - Francesco Frecentese
- Dipartimento di Farmacia, Università di Napoli Federico II, Via D. Montesano, 49, 80131 Naples, Italy; (G.A.); (B.S.); (A.C.); (R.S.); (E.P.); (F.F.); (V.S.); (G.C.)
| | - Vincenzo Santagada
- Dipartimento di Farmacia, Università di Napoli Federico II, Via D. Montesano, 49, 80131 Naples, Italy; (G.A.); (B.S.); (A.C.); (R.S.); (E.P.); (F.F.); (V.S.); (G.C.)
| | - Anna Leśniak
- Department of Pharmacotherapy and Pharmaceutical Care, Centre for Preclinical Research and Technology, Faculty of Pharmacy, Medical University of Warsaw, 1 Banacha Str., 02-097 Warsaw, Poland; (A.L.); (M.B.-Z.)
| | - Magdalena Bujalska-Zadrożny
- Department of Pharmacotherapy and Pharmaceutical Care, Centre for Preclinical Research and Technology, Faculty of Pharmacy, Medical University of Warsaw, 1 Banacha Str., 02-097 Warsaw, Poland; (A.L.); (M.B.-Z.)
| | - Giuseppe Caliendo
- Dipartimento di Farmacia, Università di Napoli Federico II, Via D. Montesano, 49, 80131 Naples, Italy; (G.A.); (B.S.); (A.C.); (R.S.); (E.P.); (F.F.); (V.S.); (G.C.)
| | - Pietro Formisano
- URT “Genomic of Diabetes”, Institute for Experimental Endocrinology and Oncology “G. Salvatore”, National Research Council (IEOS-CNR), Via Pansini 5, 80131 Naples, Italy; (M.R.A.); (P.F.)
- Department of Translational Medicine, University of Naples “Federico II”, Via Pansini 5, 80131 Naples, Italy;
| | - Ferdinando Fiorino
- Dipartimento di Farmacia, Università di Napoli Federico II, Via D. Montesano, 49, 80131 Naples, Italy; (G.A.); (B.S.); (A.C.); (R.S.); (E.P.); (F.F.); (V.S.); (G.C.)
| |
Collapse
|
3
|
Synthesis, Docking Studies and Pharmacological Evaluation of Serotoninergic Ligands Containing a 5-Norbornene-2-Carboxamide Nucleus. MOLECULES (BASEL, SWITZERLAND) 2022; 27:molecules27196492. [PMID: 36235029 PMCID: PMC9572521 DOI: 10.3390/molecules27196492] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/29/2022] [Revised: 09/20/2022] [Accepted: 09/28/2022] [Indexed: 11/09/2022]
Abstract
A new series of 5-norbornene-2-carboxamide derivatives was prepared and their affinities to the 5-HT1A, 5-HT2A, and 5-HT2C receptors were evaluated and compared to a previously synthesized series of derivatives characterized by exo-N-hydroxy-5-norbornene-2,3-dicarboximidenucleus, in order to identify selective ligands for the above-mentioned subtype receptors. Arylpiperazines represents one of the most important classes of 5-HT1AR ligands, and recent research concerning new derivatives has been focused on the modification of one or more portions of such pharmacophore. The combination of structural elements (heterocyclic nucleus, propyl chain and 4-substituted piperazine), known to be critical to the affinity to 5-HT1A receptors, and the proper selection of substituents led to compounds with high specificity and affinity towards serotoninergic receptors. The most active compounds were selected for further in vivo assays to determine their functional activity. Finally, to rationalize the obtained results, molecular docking studies were performed. The results of the pharmacological studies showed that Norbo-4 and Norbo-18 were the most active and promising derivatives for the serotonin receptor considered in this study.
Collapse
|
4
|
Ambrosio MR, Magli E, Caliendo G, Sparaco R, Massarelli P, D'Esposito V, Migliaccio T, Mosca G, Fiorino F, Formisano P. Serotoninergic receptor ligands improve Tamoxifen effectiveness on breast cancer cells. BMC Cancer 2022; 22:171. [PMID: 35168555 PMCID: PMC8845285 DOI: 10.1186/s12885-021-09147-y] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2021] [Accepted: 12/20/2021] [Indexed: 01/19/2023] Open
Abstract
Background Serotonin (or 5-Hydroxytryptamine, 5-HT) signals in mammary gland becomes dysregulated in cancer, also contributing to proliferation, metastasis, and angiogenesis. Thus, the discovery of novel compounds targeting serotonin signaling may contribute to tailor new therapeutic strategies usable in combination with endocrine therapies. We have previously synthesized serotoninergic receptor ligands (SER) with high affinity and selectivity towards 5-HT2A and 5-HT2C receptors, the main mediators of mitogenic effect of serotonin in breast cancer (BC). Here, we investigated the effect of 10 SER on viability of MCF7, SKBR3 and MDA-MB231 BC cells and focused on their potential ability to affect Tamoxifen responsiveness in ER+ cells. Methods Cell viability has been assessed by sulforhodamine B assay. Cell cycle has been analyzed by flow cytometry. Gene expression of 5-HT receptors and Connective Tissue Growth Factor (CTGF) has been checked by RT-PCR; mRNA levels of CTGF and ABC transporters have been further measured by qPCR. Protein levels of 5-HT2C receptors have been analyzed by Western blot. All data were statistically analyzed using GraphPad Prism 7. Results We found that treatment with SER for 72 h reduced viability of BC cells. SER were more effective on MCF7 ER+ cells (IC50 range 10.2 μM - 99.2 μM) compared to SKBR3 (IC50 range 43.3 μM - 260 μM) and MDA-MB231 BC cells (IC50 range 91.3 μM - 306 μM). This was paralleled by accumulation of cells in G0/G1 phase of cell cycle. Next, we provided evidence that two ligands, SER79 and SER68, improved the effectiveness of Tamoxifen treatment in MCF7 cells and modulated the expression of CTGF, without affecting viability of MCF10A non-cancer breast epithelial cells. In a cell model of Tamoxifen resistance, SER68 also restored drug effect independently of CTGF. Conclusions These results identified serotoninergic receptor ligands potentially usable in combination with Tamoxifen to improve its effectiveness on ER+ BC patients. Supplementary Information The online version contains supplementary material available at 10.1186/s12885-021-09147-y.
Collapse
Affiliation(s)
- Maria Rosaria Ambrosio
- Institute for Experimental Endocrinology and Oncology "G. Salvatore" - National Research Council (IEOS-CNR), Via Pansini 5, 80131, Naples, Italy.,Department of Translational Medicine, University of Naples "Federico II" (DiSMeT-UniNa), Via Pansini 5, 80131, Naples, Italy
| | - Elisa Magli
- Department of Pharmacy, University of Naples "Federico II" (UniNa), Via Montesano 49 -, 80131, Naples, Italy
| | - Giuseppe Caliendo
- Department of Pharmacy, University of Naples "Federico II" (UniNa), Via Montesano 49 -, 80131, Naples, Italy
| | - Rosa Sparaco
- Department of Pharmacy, University of Naples "Federico II" (UniNa), Via Montesano 49 -, 80131, Naples, Italy
| | - Paola Massarelli
- Department of Medicine, Surgery and Neuroscience, University of Siena, Strada delle Scotte 6 -, 53100, Siena, Italy
| | - Vittoria D'Esposito
- Institute for Experimental Endocrinology and Oncology "G. Salvatore" - National Research Council (IEOS-CNR), Via Pansini 5, 80131, Naples, Italy.,Department of Translational Medicine, University of Naples "Federico II" (DiSMeT-UniNa), Via Pansini 5, 80131, Naples, Italy
| | - Teresa Migliaccio
- Department of Translational Medicine, University of Naples "Federico II" (DiSMeT-UniNa), Via Pansini 5, 80131, Naples, Italy
| | - Giusy Mosca
- Department of Translational Medicine, University of Naples "Federico II" (DiSMeT-UniNa), Via Pansini 5, 80131, Naples, Italy
| | - Ferdinando Fiorino
- Department of Pharmacy, University of Naples "Federico II" (UniNa), Via Montesano 49 -, 80131, Naples, Italy
| | - Pietro Formisano
- Institute for Experimental Endocrinology and Oncology "G. Salvatore" - National Research Council (IEOS-CNR), Via Pansini 5, 80131, Naples, Italy. .,Department of Translational Medicine, University of Naples "Federico II" (DiSMeT-UniNa), Via Pansini 5, 80131, Naples, Italy.
| |
Collapse
|
5
|
Magli E, Kędzierska E, Kaczor AA, Bielenica A, Severino B, Gibuła-Tarłowska E, Kotlińska JH, Corvino A, Sparaco R, Esposito G, Albrizio S, Perissutti E, Frecentese F, Leśniak A, Bujalska-Zadrożny M, Struga M, Capasso R, Santagada V, Caliendo G, Fiorino F. Synthesis, docking studies, and pharmacological evaluation of 2-hydroxypropyl-4-arylpiperazine derivatives as serotoninergic ligands. Arch Pharm (Weinheim) 2021; 354:e2000414. [PMID: 33543794 DOI: 10.1002/ardp.202000414] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2020] [Revised: 12/17/2020] [Accepted: 01/08/2021] [Indexed: 01/02/2023]
Abstract
A new series of norbornene and exo-N-hydroxy-7-oxabicyclo[2.2.1]hept-5-ene-2,3-dicarboximide derivatives was prepared, and their affinities to the 5-HT1A , 5-HT2A , and 5-HT2C receptors were evaluated and compared with a previously synthesized series of derivatives characterized by the same nuclei, to identify selective ligands for the subtype receptors. Arylpiperazines represent one of the most important classes of 5-HT1A R ligands, and the research of new derivatives has been focused on the modification of one or more portions of this pharmacophore. The combination of structural elements (heterocyclic nucleus, hydroxyalkyl chain, and 4-substituted piperazine), known to be critical for the affinity to 5-HT1A receptors, and the proper selection of substituents resulted in compounds with high specificity and affinity toward serotoninergic receptors. The most active compounds were selected for further in vivo assays to determine their functional activity. Finally, to rationalize the obtained results, molecular docking studies were performed. The results of the pharmacological studies showed that 3e, 4j, and 4n were the most active and promising derivatives for the serotonin receptor considered in this study.
Collapse
Affiliation(s)
- Elisa Magli
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Ewa Kędzierska
- Department of Pharmacology and Pharmacodynamics, Faculty of Pharmacy with Division of Medical Analytics, Medical University of Lublin, Lublin, Poland
| | - Agnieszka A Kaczor
- Department of Synthesis and Chemical Technology of Pharmaceutical Substances with Computer Modeling Laboratory, Faculty of Pharmacy, Medical University of Lublin, Lublin, Poland.,School of Pharmacy, University of Eastern Finland, Kuopio, Finland
| | - Anna Bielenica
- Department of Biochemistry, Medical University of Warsaw, Warsaw, Poland
| | - Beatrice Severino
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Ewa Gibuła-Tarłowska
- Department of Pharmacology and Pharmacodynamics, Faculty of Pharmacy with Division of Medical Analytics, Medical University of Lublin, Lublin, Poland
| | - Jolanta H Kotlińska
- Department of Pharmacology and Pharmacodynamics, Faculty of Pharmacy with Division of Medical Analytics, Medical University of Lublin, Lublin, Poland
| | - Angela Corvino
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Rosa Sparaco
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Giovanna Esposito
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Stefania Albrizio
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Elisa Perissutti
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Francesco Frecentese
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Anna Leśniak
- Department of Pharmacodynamics, Centre for Preclinical Research and Technology, Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Poland
| | - Magdalena Bujalska-Zadrożny
- Department of Pharmacodynamics, Centre for Preclinical Research and Technology, Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Poland
| | - Marta Struga
- Department of Biochemistry, Medical University of Warsaw, Warsaw, Poland
| | - Raffaele Capasso
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Vincenzo Santagada
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Giuseppe Caliendo
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| | - Ferdinando Fiorino
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", Napoli, Italy
| |
Collapse
|
6
|
Narayanaswami V, Tong J, Fiorino F, Severino B, Sparaco R, Magli E, Giordano F, Bloomfield PM, Prabhakaran J, Mann JJ, Vasdev N, Dahl K, Kumar JSD. Synthesis, in vitro and in vivo evaluation of 11C-O-methylated arylpiperazines as potential serotonin 1A (5-HT 1A) receptor antagonist radiotracers. EJNMMI Radiopharm Chem 2020; 5:13. [PMID: 32430632 PMCID: PMC7237647 DOI: 10.1186/s41181-020-00096-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2020] [Accepted: 04/23/2020] [Indexed: 01/23/2023] Open
Abstract
Background Serotonin 1A (5-HT1A) receptors are implicated in the pathogenesis of several psychiatric and neurodegenerative disorders motivating the development of suitable radiotracers for in vivo positron emission tomography (PET) neuroimaging. The gold standard PET imaging agent for this target is [carbonyl-11C]WAY-100635, labeled via a technically challenging multi-step reaction that has limited its widespread use. While several antagonist and agonist-based PET radiotracers for 5-HT 1A receptors have been developed, their clinical translation has been hindered by methodological challenges and/or and non-specific binding. As a result, there is continued interest in the development of new and more selective 5-HT1A PET tracers having a relatively easier and reliable radiosynthesis process for routine production and with favorable metabolism to facilitate tracer-kinetic modeling. The purpose of the current study was to develop and characterize a radioligand with suitable characteristics for imaging 5-HT1A receptors in the brain. The current study reports the in vitro characterization and radiosyntheses of three candidate 5-HT1A receptor antagonists, DF-100 (1), DF-300 (2) and DF-400 (3), to explore their suitability as potential PET radiotracers. Results Syntheses of 1–3 and corresponding precursors for radiolabeling were achieved from isonicotinic, picolinic acid or picolino nitrile. In vitro binding studies demonstrated nanomolar affinity of the compounds for 5-HT1A receptors. Binding of 1–3 for other biogenic amines, neurotransmitter receptors, and transporters was negligible with the exception of moderate affinities for α1-adrenergic receptors (4–6-fold less potent than that for 5-HT1A receptor). Radioligands [11C]1–3 were efficiently prepared by 11C-O-methylation of the corresponding phenolic precursor in non-decay corrected radiochemical yields of 7–11% with > 99% chemical and radiochemical purities. Dynamic PET studies in rats demonstrated negligible brain uptake of [11C]1 and [11C]2. In contrast, significant brain uptake of [11C]3 was observed with an early peak SUV of 4–5. However, [11C]3 displayed significant off-target binding attributed to α1-adrenergic receptors based on regional distribution (thalamus>hippocampus) and blocking studies. Conclusion Despite efficient radiolabeling, results from PET imaging experiments limit the application of [11C]3 for in vivo quantification of 5-HT1A receptors. Nevertheless, derivatives of compound 3 may provide a scaffold for alternative PET radiotracers with improved selectivity for 5-HT 1A receptors or α1-adrenergic receptors.
Collapse
Affiliation(s)
- Vidya Narayanaswami
- Azrieli Centre for Neuro-Radiochemistry, Research Imaging Centre & Preclinical Imaging, Centre for Addiction and Mental Health, Toronto, Ontario, M5T-1R8, Canada
| | - Junchao Tong
- Azrieli Centre for Neuro-Radiochemistry, Research Imaging Centre & Preclinical Imaging, Centre for Addiction and Mental Health, Toronto, Ontario, M5T-1R8, Canada
| | - Ferdinando Fiorino
- Department of Pharmacy, University of Naples, Via D. Montesano, 49, 8013, Naples, Italy
| | - Beatrice Severino
- Department of Pharmacy, University of Naples, Via D. Montesano, 49, 8013, Naples, Italy
| | - Rosa Sparaco
- Department of Pharmacy, University of Naples, Via D. Montesano, 49, 8013, Naples, Italy
| | - Elisa Magli
- Department of Pharmacy, University of Naples, Via D. Montesano, 49, 8013, Naples, Italy
| | - Flavia Giordano
- Department of Pharmacy, University of Naples, Via D. Montesano, 49, 8013, Naples, Italy
| | - Peter M Bloomfield
- Azrieli Centre for Neuro-Radiochemistry, Research Imaging Centre & Preclinical Imaging, Centre for Addiction and Mental Health, Toronto, Ontario, M5T-1R8, Canada
| | - Jaya Prabhakaran
- Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York, USA
| | - J John Mann
- Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York, USA.,Department of Psychiatry, Columbia University Medical Center, New York, USA
| | - Neil Vasdev
- Azrieli Centre for Neuro-Radiochemistry, Research Imaging Centre & Preclinical Imaging, Centre for Addiction and Mental Health, Toronto, Ontario, M5T-1R8, Canada.,Department of Psychiatry, University of Toronto, Toronto, Ontario, M5T-1R8, Canada
| | - Kenneth Dahl
- Azrieli Centre for Neuro-Radiochemistry, Research Imaging Centre & Preclinical Imaging, Centre for Addiction and Mental Health, Toronto, Ontario, M5T-1R8, Canada.
| | - J S Dileep Kumar
- Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York, USA.
| |
Collapse
|
7
|
Magli E, Severino B, Corvino A, Perissutti E, Frecentese F, Saccone I, Giordano F, Castro M, Brea J, Loza MI, Santagada V, Caliendo G, Fiorino F. New Serotoninergic Ligands Containing Indolic and Methyl Indolic Nuclei: Synthesis and In Vitro Pharmacological Evaluation. Med Chem 2019; 16:517-530. [PMID: 31203804 DOI: 10.2174/1573406415666190613153220] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2019] [Revised: 04/23/2019] [Accepted: 04/29/2019] [Indexed: 11/22/2022]
Abstract
BACKGROUND Serotonin is an important biogenic amine and is implicated in wideranging physiological and physiopathological processes. Pharmacological manipulation of the serotoninergic system is believed to have a great therapeutic potential. OBJECTIVES In order to identify selective ligands for 5-HT1A, 5-HT2A and 5-HT2C receptors two series of 4-substituted piperazine derivatives, bearing indolic or methyl indolic nuclei, were synthesized. METHODS All the compounds, synthesized by standard solution methods, were evaluated for 5- HT1A, 5-HT2A and 5-HT2C receptors. The highest affine and selective compounds have been evaluated also on dopaminergic (D1 and D2) and adrenergic (α1A and α2A) receptors. RESULTS Several of the newly synthesized molecules showed affinity in the nanomolar range for 5- HT1A, 5-HT2A and 5-HT2C receptors and moderate to no affinity for other relevant receptors (D1, D2, α1A and α2A). CONCLUSION Compounds 7f and 10a showed a nanomolar affinity towards 5-HT1A with an in vitro pharmacologic profile compatible with antipsychotic drugs.
Collapse
Affiliation(s)
- Elisa Magli
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| | - Beatrice Severino
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| | - Angela Corvino
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| | - Elisa Perissutti
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| | - Francesco Frecentese
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| | - Irene Saccone
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| | - Flavia Giordano
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| | - Marián Castro
- USEF Screening Platform-BioFarma Research Group, Center for Research in Molecular Medicine and Chronic Diseases, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
| | - José Brea
- USEF Screening Platform-BioFarma Research Group, Center for Research in Molecular Medicine and Chronic Diseases, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
| | - María I Loza
- USEF Screening Platform-BioFarma Research Group, Center for Research in Molecular Medicine and Chronic Diseases, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
| | - Vincenzo Santagada
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| | - Giuseppe Caliendo
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| | - Ferdinando Fiorino
- Dipartimento di Farmacia, Universita degli Studi di Napoli "Federico II", Via D. Montesano, 49, 80131, Napoli, Italy
| |
Collapse
|
8
|
Magli E, Kędzierska E, Kaczor AA, Severino B, Corvino A, Perissutti E, Frecentese F, Saccone I, Massarelli P, Gibuła‐Tarłowska E, Kotlińska JH, Santagada V, Caliendo G, Fiorino F. Synthesis, docking studies, and pharmacological evaluation of 5HT
2C
ligands containing the
N
′‐cyanoisonicotinamidine or
N
′‐cyanopicolinamidine nucleus. Arch Pharm (Weinheim) 2019; 352:e1800373. [DOI: 10.1002/ardp.201800373] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2018] [Revised: 02/07/2019] [Accepted: 02/09/2019] [Indexed: 01/18/2023]
Affiliation(s)
- Elisa Magli
- Dipartimento di FarmaciaUniversità di Napoli “Federico II”Naples Italy
| | - Ewa Kędzierska
- Department of Pharmacology and Pharmacodynamics, Faculty of Pharmacy with Division of Medical AnalyticsMedical University of LublinLublin Poland
| | - Agnieszka A. Kaczor
- Department of Synthesis and Chemical Technology of Pharmaceutical Substances with Computer Modeling Laboratory, Faculty of Pharmacy with Division of Medical AnalyticsMedical University of LublinLublin Poland
- School of PharmacyUniversity of Eastern FinlandKuopio Finland
| | - Beatrice Severino
- Dipartimento di FarmaciaUniversità di Napoli “Federico II”Naples Italy
| | - Angela Corvino
- Dipartimento di FarmaciaUniversità di Napoli “Federico II”Naples Italy
| | - Elisa Perissutti
- Dipartimento di FarmaciaUniversità di Napoli “Federico II”Naples Italy
| | | | - Irene Saccone
- Dipartimento di FarmaciaUniversità di Napoli “Federico II”Naples Italy
| | - Paola Massarelli
- Dipartimento di Scienze Mediche, Chirurgiche e NeuroscienzeUniversità di SienaSiena Italy
| | - Ewa Gibuła‐Tarłowska
- Department of Pharmacology and Pharmacodynamics, Faculty of Pharmacy with Division of Medical AnalyticsMedical University of LublinLublin Poland
| | - Jolanta H. Kotlińska
- Department of Pharmacology and Pharmacodynamics, Faculty of Pharmacy with Division of Medical AnalyticsMedical University of LublinLublin Poland
| | | | - Giuseppe Caliendo
- Dipartimento di FarmaciaUniversità di Napoli “Federico II”Naples Italy
| | | |
Collapse
|
9
|
Kędzierska E, Fiorino F, Gibuła E, Corvino A, Giordano F, Herbet M, Dudka J, Poleszak E, Wlaź P, Kotlińska JH. Anxiolytic‐like effects of the new arylpiperazine derivatives containing isonicotinic and picolinic nuclei: behavioral and biochemical studies. Fundam Clin Pharmacol 2019; 33:254-266. [DOI: 10.1111/fcp.12443] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2018] [Revised: 11/14/2018] [Accepted: 11/26/2018] [Indexed: 12/19/2022]
Affiliation(s)
- Ewa Kędzierska
- Department of Pharmacology and Pharmacodynamics Faculty of Pharmacy with Division of Medical Analytics Medical University of Lublin Chodźki 4a 20‐093 Lublin Poland
| | - Ferdinando Fiorino
- Department of Pharmacy University of Naples Federico II Via D. Montesano 49 80131 Naples Italy
| | - Ewa Gibuła
- Department of Pharmacology and Pharmacodynamics Faculty of Pharmacy with Division of Medical Analytics Medical University of Lublin Chodźki 4a 20‐093 Lublin Poland
| | - Angela Corvino
- Department of Pharmacy University of Naples Federico II Via D. Montesano 49 80131 Naples Italy
| | - Flavia Giordano
- Department of Pharmacy University of Naples Federico II Via D. Montesano 49 80131 Naples Italy
| | - Mariola Herbet
- Department of Toxicology Faculty of Pharmacy with Division of Medical Analytics Medical University of Lublin Chodźki 8 20‐093 Lublin Poland
| | - Jarosław Dudka
- Department of Toxicology Faculty of Pharmacy with Division of Medical Analytics Medical University of Lublin Chodźki 8 20‐093 Lublin Poland
| | - Ewa Poleszak
- Department of Applied Pharmacy Faculty of Pharmacy with Division of Medical Analytics Medical University of Lublin Chodźki 1 20‐093 Lublin Poland
| | - Piotr Wlaź
- Department of Animal Physiology Faculty of Biology and Biotechnology Maria Curie‐Skłodowska University Akademicka 19 20‐033 Lublin Poland
| | - Jolanta H. Kotlińska
- Department of Pharmacology and Pharmacodynamics Faculty of Pharmacy with Division of Medical Analytics Medical University of Lublin Chodźki 4a 20‐093 Lublin Poland
| |
Collapse
|
10
|
Fiorino F, Magli E, Kędzierska E, Ciano A, Corvino A, Severino B, Perissutti E, Frecentese F, Di Vaio P, Saccone I, Izzo AA, Capasso R, Massarelli P, Rossi I, Orzelska-Gòrka J, Kotlińska JH, Santagada V, Caliendo G. New 5-HT1A, 5HT2A and 5HT2C receptor ligands containing a picolinic nucleus: Synthesis, in vitro and in vivo pharmacological evaluation. Bioorg Med Chem 2017; 25:5820-5837. [DOI: 10.1016/j.bmc.2017.09.018] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2017] [Revised: 09/05/2017] [Accepted: 09/13/2017] [Indexed: 02/02/2023]
|
11
|
Fiorino F, Ciano A, Magli E, Severino B, Corvino A, Perissutti E, Frecentese F, Di Vaio P, Izzo AA, Capasso R, Massarelli P, Nencini C, Rossi I, Kędzierska E, Orzelska-Gòrka J, Bielenica A, Santagada V, Caliendo G. Synthesis, in vitro and in vivo pharmacological evaluation of serotoninergic ligands containing an isonicotinic nucleus. Eur J Med Chem 2016; 110:133-50. [PMID: 26820556 DOI: 10.1016/j.ejmech.2016.01.021] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2015] [Revised: 01/13/2016] [Accepted: 01/14/2016] [Indexed: 01/08/2023]
Abstract
Isonicotinamide derivatives, linked to an arylpiperazine moiety, were prepared and their affinity to 5-HT1A, 5-HT2A and 5-HT2C receptors were evaluated. The combination of structural elements (heterocyclic nucleus, alkyl chain and 4-substituted piperazine) known to play critical roles in affinity for serotoninergic receptors and the proper selection of substituents led to compounds with high specificity and affinity towards serotoninergic receptors. In binding studies, several molecules showed high affinity in nanomolar and subnanomolar range at 5-HT1A, 5-HT2A and 5-HT2C receptors and moderate or no affinity for other relevant receptors (D1, D2, α1 and α2). N-(3-(4-(bis(4-fluorophenyl)methyl)piperazin-1-yl)propyl)isonicotinamide (4s) with Ki = 0.130 nM, was the most active and selective derivative for the 5-HT1A receptor compared to other serotoninergic, dopaminergic and adrenergic receptors. Compound 4o, instead, showed 5-HT2A affinity values in subnamolar range. Moreover, the compounds having better affinity and selectivity binding profile towards 5-HT1A and 5-HT2A receptors were selected in order to be tested by in vitro and in vivo assays to determine their functional activity.
Collapse
Affiliation(s)
- Ferdinando Fiorino
- Dipartimento di Farmacia Università di Napoli "Federico II", Via D. Montesano, 49, 80131, Naples, Italy.
| | - Antonio Ciano
- Dipartimento di Farmacia Università di Napoli "Federico II", Via D. Montesano, 49, 80131, Naples, Italy
| | - Elisa Magli
- Dipartimento di Farmacia Università di Napoli "Federico II", Via D. Montesano, 49, 80131, Naples, Italy
| | - Beatrice Severino
- Dipartimento di Farmacia Università di Napoli "Federico II", Via D. Montesano, 49, 80131, Naples, Italy
| | - Angela Corvino
- Dipartimento di Farmacia Università di Napoli "Federico II", Via D. Montesano, 49, 80131, Naples, Italy
| | - Elisa Perissutti
- Dipartimento di Farmacia Università di Napoli "Federico II", Via D. Montesano, 49, 80131, Naples, Italy
| | - Francesco Frecentese
- Dipartimento di Farmacia Università di Napoli "Federico II", Via D. Montesano, 49, 80131, Naples, Italy
| | - Paola Di Vaio
- Dipartimento di Farmacia Università di Napoli "Federico II", Via D. Montesano, 49, 80131, Naples, Italy
| | - Angelo A Izzo
- Dipartimento di Farmacia Università di Napoli "Federico II", Via D. Montesano, 49, 80131, Naples, Italy
| | - Raffaele Capasso
- Dipartimento di Farmacia Università di Napoli "Federico II", Via D. Montesano, 49, 80131, Naples, Italy
| | - Paola Massarelli
- Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze Università di Siena, Via delle Scotte, 6, 53100, Siena, Italy
| | - Cristina Nencini
- Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze Università di Siena, Via delle Scotte, 6, 53100, Siena, Italy
| | - Ilaria Rossi
- Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze Università di Siena, Via delle Scotte, 6, 53100, Siena, Italy
| | - Ewa Kędzierska
- Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, 20-093 Lublin, Poland
| | - Jolanta Orzelska-Gòrka
- Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, 20-093 Lublin, Poland
| | - Anna Bielenica
- Department of Biochemistry, Medical University of Warsaw, 02-097 Warszawa, Poland
| | - Vincenzo Santagada
- Dipartimento di Farmacia Università di Napoli "Federico II", Via D. Montesano, 49, 80131, Naples, Italy
| | - Giuseppe Caliendo
- Dipartimento di Farmacia Università di Napoli "Federico II", Via D. Montesano, 49, 80131, Naples, Italy
| |
Collapse
|
12
|
Fiorino F, Magli E, Severino B, Corvino A, Ciano A, Perissutti E, Frecentese F, Massarelli P, Nencini C, Santagada V, Caliendo G. Synthesis andIn VitroPharmacological Evaluation of Novel 2-Hydroxypropyl-4-arylpiperazine Derivatives as Serotoninergic Ligands. Arch Pharm (Weinheim) 2014; 347:698-706. [DOI: 10.1002/ardp.201400174] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2014] [Revised: 06/18/2014] [Accepted: 06/24/2014] [Indexed: 01/10/2023]
Affiliation(s)
- Ferdinando Fiorino
- Dipartimento di Farmacia; Università degli Studi di Napoli “Federico II”; Napoli Italy
| | - Elisa Magli
- Dipartimento di Farmacia; Università degli Studi di Napoli “Federico II”; Napoli Italy
| | - Beatrice Severino
- Dipartimento di Farmacia; Università degli Studi di Napoli “Federico II”; Napoli Italy
| | - Angela Corvino
- Dipartimento di Farmacia; Università degli Studi di Napoli “Federico II”; Napoli Italy
| | - Antonio Ciano
- Dipartimento di Farmacia; Università degli Studi di Napoli “Federico II”; Napoli Italy
| | - Elisa Perissutti
- Dipartimento di Farmacia; Università degli Studi di Napoli “Federico II”; Napoli Italy
| | - Francesco Frecentese
- Dipartimento di Farmacia; Università degli Studi di Napoli “Federico II”; Napoli Italy
| | - Paola Massarelli
- Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze; Università di Siena; Siena Italy
| | - Cristina Nencini
- Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze; Università di Siena; Siena Italy
| | - Vincenzo Santagada
- Dipartimento di Farmacia; Università degli Studi di Napoli “Federico II”; Napoli Italy
| | - Giuseppe Caliendo
- Dipartimento di Farmacia; Università degli Studi di Napoli “Federico II”; Napoli Italy
| |
Collapse
|